T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice

Cancer Research

Volumn 56, Issue 22, 1996, Pages 5113-5119

  Condorelli, G L ^a   Facchiano, F ^a,c   Valtieri, M ^b   Proietti, E ^b   Vitelli, L ^b   Lulli, V ^b   Huebner, K ^a   Peschle, C ^a,b   Croce, C M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN P53; TRANSCRIPTION FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; FLUORESCENCE ACTIVATED CELL SORTER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LEUKEMOGENESIS; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; SURVIVAL RATE; T CELL LYMPHOMA; THYMUS; TRANSGENIC MOUSE;

ADENOVIRUS E2 PROTEINS; ANIMALS; ANTIGENS, CD3; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DNA-BINDING PROTEINS; GENE DELETION; GENES, P53; HUMANS; LEUKEMIA, T-CELL, ACUTE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ONCOGENE PROTEINS, FUSION; ONCOGENES; PHENOTYPE; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTES; THYMUS GLAND; TRANSCRIPTION FACTORS;

EID: 0029844127     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Cleary, M L Oncogenic conversion of transcription factors by chromosomal translocations Cell, 66: 619-622, 1991.
2. Rabbitts, T. H. Chromosomal translocations in human cancer. Nature (Lond.), 372: 143-149, 1994.
3. Begley, C G , Aplan, P D., Davey, M. P , Nakahara, K., Tchorz, K., Kurtzberg, J., Hershfield, M. S., Haynes, B F., Cohen, D. I , Waldmann, T. A. and Kirsh, I. R. Chromosomal translocation in a human leukemia stem-cell line disrupts the T-cell antigen receptor [δ]-chain diversity region and results in a previously unreported fusion transcript. Proc. Natl Acad Sci. USA, 86: 2031-2035, 1989.
4. Finger, L. R., Kagan, G., Christopher, C., Kurtzberg, J., Hershfield, M., Nowell, P C , and Croce, C. M. Involvement of TCL-5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc. Natl. Acad Sci. USA, 86: 5039-5043, 1989.
5. Chen, Q , Cheng, J T., Tsai, L H., Schneider, N., Buchanan, G., Carroll, A., Crist, W., Ozanne, B., Siciliano, M. J , and Baer, R. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes helix-loop-helix protein. EMBO J., 9: 415-424, 1990.
6. Murre, C., McCaw, P. S., and Baltimore, D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell, 56: 777-783, 1989.
7. Bernard, O., Lecointe, N., Jonveaux, P., Souyn, M., Mauchauffé, M., Berger, R., Larsen, C J , and Mathieu-Mahul, D. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5′ part of the tal-1 gene. Oncogene, 6: 1477-1488, 1991.
8. Visvader, J., Begley, C. G., and Adams, J. M Differential expression of the LYL, SCL, and E2A helix-loop-helix genes within the hematopoietic system. Oncogene, 6: 187-194, 1991.
9. Bernard, O , Azogui, O., Lecointe, N., Mugneret, F., Berger, R., Larsen, C J., and Mathieu-Mahul, D. A third tal-1 promoter is specifically used in human T cell leukemia. J Exp. Med , 176: 919-925, 1992
10. Brown, L., Cheng, J T , Chen, Q., Siciliano, M. J., Crist, W., Buchanan, G., and Baer, R. Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J , 9 3343-3351, 1990
11. Bash, R. O , Hall, S., Timmons, C. F., Crist, W. M , Amylon, M , Smith, R. G., and Baer, R. Does activation of the TALI gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study. Blood, 86 666-676, 1995.
12. Mouthon, M. A , Bernard, O , Mitjavila, M. T., Romeo, P. H., Vainchenker, W., and Mathieu-Mahul. D Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood. 81: 647-655, 1993.
13. Pulford, K , Lecointe, N., Leroy-Viard, K., Jones, M., Mathieu-Mahul, D., and Mason, D. Y. Expression of TAL-I proteins in human tissues. Blood. 85: 675-684, 1995.
14. Condorelli, G. L , Vitelh, L., Valtieri, M , Marta, I., Montesoro, E , Lulli, V., Baer, R., and Peschle, C. Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation. Blood, 86: 164-175, 1995.
15. Shivdasani, R A., Mayer, E. L., and Orkin, S. H Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-I/SCL. Nature (Lond), 373: 432-434, 1995.
16. Robb, L , Lyons, I , Li, R , Hartley, L., Kontgen, F., Harvey, R. P , Metcalf, D , and Begley, C G. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene Proc. Natl Acad. Sci. USA, 92: 7075-7079, 1995.
17. Porcher, C., Swat, W , Rockwell, K., Fujiwara, Y., Alt, F. W , and Orkin, S H. The T cell leukemia oncoprotein SCL/tal1 is essential for development of all hematopoietic lineages. Cell, 88: 47-57, 1996.
18. Mellentin, J D , Smith, S D., and Cleary, M. L Lyl-I, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell, 58: 77-83, 1989.
19. Xia, Y., Brown, L , Yang, C. Y. C , Tsan, J. T , Siciliano, M. J., Espinosa, R., III, Le Beau, M M , and Baer, R. J. TAL2, a helix-loop-helix gene activated by the (7,9) (q34,q32) translocation in human T-cell leukemia. Proc Natl. Acad. Sci. USA, 88: 11416-11420, 1991.
20. Hsu, H. L., Cheng, J. T., Chen, Q., and Baer, R. Enhancer-binding activity of the tal-1 oncoprotein in association with the E12/E47 helix-loop-helix proteins. Mol. Cell. Biol, 11, 3037-3042, 1991.
21. Hsu, H L., Huang, L , Tsan, J T., Funk, W., Wright, W. E., Hu, J. S., Kingston, R. E., and Baer, R. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol. Cell Biol , 14: 1256-1265, 1994.
22. Hsu, H. L., Waldman, I., and Baer, R Formation of in vivo complexes between the TAL1 and E2A polypeptides in leukemic T cells Proc Natl. Acad. Sci USA, 91 3181-3185, 1994.
23. Voronova, A. F , and Lee, F. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. Proc Natl. Acad. Sci. USA, 91: 5952-5956, 1994
24. Robb, L., Rasko, J. E J., Bath, M. L , Strasser, A., and Begley, G. C scl, a gene frequently activated in human T cell leukemia, does not induce lymphomas in transgenic mice Oncogene, 10, 205-209, 1995.
25. Condorelli, G. L., Tocci, A., Botta, R , Facchiano, F., Testa, U., Vitelli, L , Valtieri, M., and Peschle, C. Ectopic tal-1 expression in myeloid precursors and nonhematopoietic cells lines: proliferative/anti-apoptotic effects coupled with differentiation blockade, submitted for publication
26. Chaffin, K E., Beals, C. R , Wilkie, T M , Forbush, K. A , Simon, M. I , and Perlmutter, R M. Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase. EMBO J., 9: 3821-3829, 1990
27. Hogan, B., Constantini, F., and Lacy, E Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1996
28. Bindl, J M , and Warnke, R A Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in coplin jars. Am. J. Pathol. 85, 490-493, 1986.
29. Sentman, C L , Shutter, J. R , Hockenbery, D , Kanagawa, O., and Korsmeyer, S. J. bcl-2 inhibits multiple forms of apoptosis by not negative selection in thymocytes. Cell, 67: 879-888, 1991.
30. Reynolds, P J, Lesley, J., Trotter, J , Schulte, R , Hyman, R., and Sefton, B. M. Changes in the relative abundance of type I and type II lck mRNA transcripts suggest differential promoter usage during T-cell development. Mol. Cell Biol , 10, 4266-4270, 1990.
31. Wildin, R. S., Garvin, A. M , Pawar, S , Lewis, D B , Abraham, K. M , Forbush, K. A., Ziegler, S. F., Allen, J M., and Perlmutter, R. M. Developmental regulation of lck gene expression in T lymphocytes J Exp Med , 173: 383-393, 1991
32. Metz, T., Harris, A W., and Adams, J M Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell, 82: 29-36, 1995
33. Soddu, S., Blandino, G., Scardigli, R., Martinelli, R., Rizzo, M. G., Crescenzi, M., and Sacchi, A. Wild-type p53 induces diverse effects in 32D cells expressing different oncogenes. Mol. Cell. Biol., 16: 487-495, 1996.
34. Valge-Archer, V. E., Osadi, H., Warren, A. J., Forster, A., Li, J., Baer, R., and Rabbitts, T H. The LIM protein RBTN2 and the basic helix-loop-helix protein TALI are present in a complex in erythroid cells Proc. Natl Acad Sci USA, 91: 8617-8621, 1994.
35. Waldman, I., Li, J., Bash, R. O., Forster, A , Osada, H , Rabbitts, T. H., and Baer, R Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J., 13: 4831-4839, 1994
36. Royer-Pokora, B., Fleischer, B., Ragg, S., Loos, U., and Williams, D. Molecular cloning of the translocation breakpoint in T-ALL 11;14 (p13;q11) genomic map of TCR alpha and delta region on chromosome 14q11 and long-range map of region 11p13. Hum. Genet, 82: 264-270, 1989
37. Royer-Pokora, B., Loos, U., and Ludwig, W. D TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11:14) (p13:q11). Oncogene, 6: 1887-1893, 1991.
38. Boehm, T., Foroni, L., Kaneko, Y , Perutz, M. F., and Rabbitts, T H The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc. Natl. Acad. Sci USA, 88: 4367-4371, 1991.
39. Warren, A J , Colledge, W H., Carlton, M. B., Evans, M J , Smith, A. J., and Rabbins, T. H. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development Cell, 78, 45-57, 1994.
40. Larson, R. C., Fisch, P , Larson, T. A , Lavenir, I , Langford, T., King, G., and Rabbins, T. H T cell tumours of disparate phenotype in mice transgenic for Rbtn-2. Oncogene, 9: 3675-3681, 1994.
41. Larson, R. C , Lavenir, I , Larson, T. A., Baer, R., Warren, A J., Waldman, I , Nottage, K., and Rabbitts, T. H Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumongenesis in transgenic mice. EMBO J., 15: 1021-1027, 1996.
42. Donehower, L. A , Harvey, M., Slagle, B. L., McArthur, M. J , Montgomery, C. A., Butel, J. S , and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Nature (Lond), 356: 215-221, 1992.
43. Harvey, M., McArthur, M J., Montgomery, C. A , Butel, J S , Bradley, A., and Donehower, L. A. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet , 5: 225-229, 1993.
44. Donehower, L. A., Godley, L. A , Aldaz, C. M , Pyle, R., Shi, Y P , Pinkel, D , Gray, J , Bradley, A., Medina, D., and Varmus, H E. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev., 9: 882-895, 1995.
45. Leroy-Viard, K., Vinit, M. A., Lecointe, N., Jouault, H., Hibner, U., Romeo, P. H., and Mathieu-Mahul, D. Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion EMBO J , 14: 2341-2349, 1995.
46. Bain, G , Maandag, E. C., Izon, D. J , Amsen, D., Kruisbeek, A. M., Weintraub, B. C., Krop, I., Schlissel, M. S., Feeney, A. J., and van Roon, M. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell, 79: 885-892, 1994.
47. Zhuang, Y., Soriano, P., and Weintraub, H. The helix-loop-helix gene E2A is required for B cell formation. Cell. 79: 875-884, 1994